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Copyright © 200? JCBN Summary Astaxanthin (ATX), a naturally occurring carotenoid pigment, is a powerful
biological antioxidant. In the present study, we investigated whether ATX pharmacologically
offers neuroprotection against oxidative stress by cerebral ischemia. We found that the
neuroprotective efficacy of ATX at the dose of 30 mg/kg (n = 8) was 59.5% compared with
the control group (n = 3). In order to make clear the mechanism of ATX neuroprotection,
the up-regulation inducible nitric oxide synthase (iNOS) and heat shock proteins (HSPs)
together with the oxygen glucose deprivation (OGD) in SH-SY5Y cells were also investigated.
The induction of various factors involved in oxidative stress processes such as iNOS was
suppressed by the treatment of ATX at 25 and 50 µM after OGD-induced oxidative stress. In
addition, Western blots showed that ATX elevated of heme oxygenase-1 (HO-1; Hsp32) and
Hsp70 protein levels in in vitro. These results suggest that the neuroprotective effects of ATX
were related to anti-oxidant activities in global ischemia.
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Introduction
Ischemic stroke occurs when the blood supply to the brain
is obstructed. It is a common cause of death and disability
in westernized society. Involvement of oxidative stress in
neuronal loss after stroke is well established. Ischemia-
induced neuronal loss is initiated by the release of excitatory
neurotransmitters, which leads to membrane depolarization,
increase in intracellular calcium concentration, and produc-
tion of nitric oxide (NO) and reactive oxygen species (ROS),
that is, superoxide anion radical, hydrogen peroxide and
highly cytotoxic byproduct hydroxyl radical. Several com-
ponents of ROS have been found to be generated after
ischemic reperfusion injury and play an important role in
the neuronal loss after cerebral ischemia [1]. However,
many antioxidants (tempol, LY231617, LY178002 and U-
101033E) are reported to reduce ROS mediated reactions
and rescue the neurons from reperfusion induced neuronal
loss in animal models of cerebral ischemia [2–5].
Astaxanthin (3,3'-dihydroxy-β,β-carotene-4,4'-dione; ATX;
Fig. 1) is widely distributed in nature, and is the principal
pigment in crustacean shell, salmonoids, and many other
organisms. Animals cannot synthesize carotenoids de novo,
thus ultimately they must obtain these pigments from the
plants and algae that support their food chains [6]. ATX has
important metabolic functions in animals, including conver-
sion to vitamin A [7], enhancement of immune response [8]
and protection against diseases such as cancer by scavenging
oxygen radicals [9]. Ohgami et al. [10] reported that ATX
inhibits NO production as well as lipopolysaccharide
(LPS)-induced inflammation in in vivo and in vitro. The
antioxidant activity of ATX has been reported to beD.-H. Lee et al.
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approximately 10 times stronger than that of other caro-
tenoids tested, including zeaxanthin, lutein, canthaxanthin,
and β-carotene, and 550 to 1000 times greater than that of
α-tocopherol (V-E) [11, 12]. The role of ATX, as well as
that of many other antioxidant carotenoids (e.g. lycopene, β-
carotene), in reducing atherogenesis and lowering the risk of
some coronary heart diseases has been previously studied
[13]. In another study, ATX showed neuroprotective effects
in the ischemia-induced impairment of spatial memory in
mice [14]. However there is no previous reported research
about the neuroprotective action of ATX against global
cerebral ischemia.
In this study, we investigated the neuroprotective effect
of ATX in a four-vessel occlusion (4-VO) induced global
cerebral ischemia model in rats. In addition, we also studied
possible neuroprotection by measuring the amount of NO
and by comparing the activities of enzymatic scavengers
such as inducible nitric oxide synthase (iNOS) and induction
of heat shock proteins (HSPs) in an attempt to elucidate
possible mechanisms underlying ATX protection against
oxygen glucose deprivation (OGD)-induced death in SH-
SY5Y neuroblastoma cell line.
Materials and Methods
Materials
Dulbecco’s modified Eagle medium (DMEM), penicillin/
streptomycin solution, and trypsin-EDTA solution were
obtained from Gibco RBL (Grand Island, NY). Fetal calf
serum was purchased from Hyclone Laboratories (Logan,
UT). Poly-D-lysine, Hank’s Balance Salt Solution, 3-(4,5-
dimethylthioazol-2-yl) 2,5-diphenyltetrazolium bromide
(MTT), and all the other chemicals used in this study were
purchased from Sigma Chemical Co. (St. Louis, MO).
Cell culture
SH-SY5Y human neuroblastoma cells were purchased
from ATCC (Manassas, VA). Cells were cultured in DMEM/
Nutrient Mixture Ham’s F-12 (1:1) media, supplemented
with 10% fetal bovine serum, penicillin (100 IU/ml),
streptomycin (100 μg/ml), and L-glutamine (2 mM); the cell
culture medium was replaced every 2 days. The cultures
were maintained at 37°C in 95% air–5% CO2 in a humidified
incubator. The cells were grown on culture dishes pre-coated
with poly-D-lysine (50 mg/ml in sterile water) overnight.
4-Vessel occlusion for in vivo ischemia
Male Wistar rats (SLC, Tokyo, Japan), weighing 190 to
220 g (6 to 7 weeks of age) were purchased from Dae-Han
BioLab (Chungcheongbuk-do, South Korea). The animal
procedures were performed in accordance with National
Institutes of Health animal care guidelines. Transient fore-
brain ischemia was induced by 4-VO according to the
method of Pulsinelli et al. [15]. In brief, after the animals
were positioned in stereotaxic ear bars (Kopf; Tujunga, CA)
with the head tilted down at ≈30° to the horizontal, incision
of 1 cm in length was made behind the occipital bone
directly overlying the first two cervical vertebrae. The
paraspinal muscles were separated from the midline, and
the right and left alar foramina of the first cervical vertebrae
were exposed with the use of an operating microscope. A
0.5-mm diameter electrocautery needle was inserted through
each alar foramen and both vertebral arteries electro-
cauterized and permanently occluded. Next, both common
carotid arteries were isolated via a ventral, midline cervical
incision. An atraumatic arterial clasp was loosely placed
around each common carotid artery without interrupting
carotid blood flow and the incision was closed with a single
suture. On the following day, 10 min of 4-VO ischemia was
induced by tightening the clasp around the common carotid
arteries. Carotid clasps were then removed following 10 min
to restore carotid blood flow. To minimize variability among
animals, following criteria were strictly applied for the
10 min ischemic period and 20 ± 5 min post-ischemic coma:
loss of righting reflex and bilateral pupil dilation. Body
temperature was monitored and maintained at 37 ± 0.5°C
with a rectal thermistor coupled to a heating blanket
(Homeothermic Blanket Control Unit, Harvard apparatus;
Edenbridge, UK). Sham-operated animals that underwent
surgery were used for non-ischemic control.
OGD for in vitro ischemia
Cultures were placed in an anaerobic chamber (Forma
Scientific) that contained a gas mixture of 5% CO2, 10%
Fig. 1. Chemical structure of astaxanthin.Neuroprotective Effects of Astaxanthin in SH-SY5Y Cells
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H2 and 85% N2 (<0.2% O2). Culture medium was replaced
by thorough exchange with deoxygenated, glucose-free
balanced salt solution containing the following (mmol/L):
116 NaCl, 5.4 KCl, 0.8 MgSO4, 1 NaH2PO4, 26.2 NaHCO3,
1.8 CaCl2, 0.01 glycine and 0.6 L-arginine; plates were then
placed in a 37°C humidified incubator within the chamber
for 90 min. Cultures were subsequently removed from the
incubator, the exposure medium was exchanged with
oxygenated MEM, and cultures were returned to a 37°C 5%
CO2-containing normoxic (21% O2) incubator. The medium
was supplemented with L-arginine to prevent this amino
acid substrate of NOS from being limiting.
Histology
At 7 days after reperfusion, the animals were anesthetized
and perfused with heparinized physiologic saline, and their
brains fixed by 4% paraformaldehyde in 0.1 M phosphate
buffer (pH 7.4). The brains were quickly removed from the
skull and post-fixed by immersion, cryoprotected in 30%
sucrose. Fixed brains were serially sectioned parallel to
the coronal plane on a sliding microtome (HM440E, Zeiss,
Germany) with the thickness set at 30 μm and the sections
were stained with 0.5% cresyl violet. The number of intact
neurons in a 1 mm length of the middle portion of the
hippocampal CA1 subfield in the total three coronal sections
per animal was counted by three blinded observers using a
microscope at ×400 magnification. Only whole neurons with
visible nucleus were counted. The histogram was plotted on
the basis of the mean ± standard deviation values. Data from
each group was analyzed by use of Student’s t test.
Administration of ATX
For the assessment of neuroprotective effects, ATX
(purchased from Sigma, St. Louis, MO) was dissolved in
pure ethanol. Animals that had been subjected to 10 min
ischemia as described below were randomly divided into
two groups. Either a solution of ATX (30 mg/kg) or ethanol
was intra-peritoneally injected into the two groups of
animals at 0 and 90 min of cerebral reperfusion.
Cell viability assay
SH-SY5Y cells were seeded at a density of 3 × 104 cells
per well on collagen coated 96-well plates and maintained
at 37°C in a 5% CO2 atmosphere. ATX was dissolved and
diluted with 0.1% DMSO (10, 25, 50 and 100 μM). Final
concentrations of organic solvents were always less than
0.1%, and they have no effects on cell viability. SH-SY5Y
cells were pretreated with diluted ATX for 90 min before the
exposure to OGD. After treatment, 50 μl of MTT (2 mg/ml
stock solution, Sigma) was added and the plates were
incubated for an additional 4 h. 150 μl of DMSO was added
to dissolve the formazan and 20 μl of Sorenson’s glycine
buffer was added to obtain the highest absorbance at
570 nm. After 20 min of gentle shaking, each plate was read
at 570 nm using a microplate reader. The IC50 values were
determined by plotting the drug concentration versus the
survival ratio of the treated cells. All the experiments were
performed in triplicate, and graphic results are shown as
mean ± SEM corresponding to 6 separate experiments.
Measurement of NO
Nitrite, measured by Griess reaction, was taken as a
measure of NO production. Briefly, 100 μl of culture super-
natant (24 h) was reacted with an equal volume of Griess
reagent (1 part 0.1% naphthylethylene-diamine, 1 part 1%
sulfanilamide in 5% H3PO4) in 96-well tissue culture plates
for 10 min at room temperature in the dark. The absorbance
at 540 nm was determined using a microplate reader
(spectraMAX 340, Molecular Devices, Sunnyvale, CA).
Immunobloting
Total protein extraction and western blot analysis was
performed as described in our earlier studies [16]. For this
study, the protein transferred membranes were incubated
with rabbit anti-mouse iNOS (1:2000, Calbiochem, San
Diego, CA), Hsp70 (1 μg/ml, Calbiochem), β-actin (1:5000,
Calbiochem), PARP-1 (1:1000, Santacruz) and Heme
oxygenase-1 (Hsp32; HO-1) (1 mg/ml, Stressgene). The
proteins were detected by a chemiluminescence detection
system according to the manufacturer’s instructions (ECL,
Amersham, Berkshire, UK). The band intensity was quantified
with a densitometric scanner (PDI, Huntington Station, NY).
Statistical analysis
All data were presented as mean ± SEM. Statistical com-
parison between different treatments was done by Student’s
t test. Differences with p value<0.05 were considered
statistically significant.
Results
Neuroprotective effect of ATX on global cerebral ischemia
The body temperature of animals exposed to ischemia
was monitored for 5 h after ischemia-reperfusion. There was
no significant difference in body temperature between saline
treated group and ATX treated groups at any time point
recorded indicating that neuroprotective effects of ATX
were not due to decrease in body temperature (Fig. 2A). The
neuroprotective effect of ATX on CA1 hippocampal neurons
was evaluated by measuring the neuronal cell density in the
CA1 hippocampal region at 7 days after 10 min ischemia.
The brain tissue sections of the dorsal hippocampus were
stained with cresyl violet to display the selective delayed
neuronal loss in the CA1 hippocampal region. In the sham
operated group, the most of the CA1 pyramidal neurons in
the CA1 region showed an unchanged staining patternD.-H. Lee et al.
J. Clin. Biochem. Nutr.
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Fig. 2. Neuroprotective effect of ATX on global cerebral ischemia. (A) Rectal temperatures were measured in rats for 5 h after global
ischemia-reperfusion. Animals were administered with ATX of 30 mg/kg (n = 7) at 0 and 300 min following 10-min ischemia,
respectively. Number in parenthesis represents the number of animals. B–H. Representative photomicrographs of Cresyl violet-
stained hippocampal regions of sham-operated animals (B, C) or animals that had been subjected to 10 min ischemia followed by
treatment with either saline (D, E) or 30 mg/kg of ATX (F, G). Boxed regions in B, D and F are shown in C, E and G, respectively.
The 10 min ischemia caused selective and delayed neuronal cell loss in the hippocampal CA1 region (D, E). In contrast, ATX
treatment conferred neuroprotection by markedly reducing the number of damaged pyramidal cells in the CA1 subfield (F, G).
Scale bar is 100 µm. (H) Assessment of neuroprotective effects of ATX. Either ethanol or ATX (10, 20 and 30 mg/kg) was intra-
peritoneally administered into animals following 10 min ischemia. Seven days later, neuronal cell density in CA1 region was
measured by Nissl staining. Asterisks indicate statistically significant differences from saline-treated ischemic group (p<0.05).
Sham, sham-operated animals (n = 6); Saline, ethanol-treated animals following ischemia (n = 5); ATX, ATX-treated animals
following ischemia (n = 5 for 10 mg/kg, 20 mg/kg and 30 mg/kg). (I) Lysates containing equal amounts of protein (20 µg) were
separated by SDS-PAGE and immunoblotted. Actin was used to confirm the equal amount of proteins loaded in each lane.Neuroprotective Effects of Astaxanthin in SH-SY5Y Cells
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(Fig. 2-B: a, d). In the saline treated group (control group),
the CA1 region was weakly stained, and the neuronal cell
damage limitedly occurred in the CA1 region. Pyramidal
neurons underwent a coagulative cellular change and were
damaged with characteristic apparent gliosis (Fig. 2-B: b
and e). The ATX treated group (at a dose 30 mg/kg, i.p.) was
significantly reduced due to the number of coagulated and
damaged pyramidal neurons in the CA1 region (Fig. 2-B: c
and f). Apoptosis was induced in the control group shown by
Fig. 2-B: b and e. Apoptotic cells were induced due to some
external or internal stimuli-cells shrank, losing their intrinsic
shapes established according to their differentiation.
Additionally, as the shrinkage broke the junctions with
surrounding cells, the interaction was interrupted between
apoptotic cells and the cells adjacent to them. The charac-
teristic pyramidal morphology of the apoptotic cells
changed. In the saline treated group, neuronal cells were
found to undergo apoptosis (Fig. 2-B: e). Also, in the ATX
treated group apoptotic cells appeared in the detached
cells from CA1 region. In contrast, the attached neuronal
cells in the CA1 region showed morphology similar to the
pyramidal normal cells (Fig. 2-B: f). ATX (at a dose 30
mg/kg) was intraperitoneally administered at 30 min after
ischemia. The control group was orally administered with
a saline solution (administration volume, 1.0 ml/kg). Viable
neuronal cells were measured to be 338.3 ± 19.5 neurons/
mm2 in the sham-operated group and 103.6 ± 11.3 neurons/
mm2 in the control group. In the ATX treated group, viable
neuronal cells at a dose of 30 mg/kg were measured to be
247.6 ± 10.7 neurons/mm2 (Fig. 2-C). The neuroprotective
percent at a dose of 30 mg/kg is 59.5%. (***p<0.001).
Based on our findings showing that ischemia causes
apoptotic death of nuoronal cells, we assessed whether
ATX inhibits apoptotic cell death. As poly (ADP-ribose)
polymerase (PARP-1) cleavage is a hallmark of apoptosis.
PARP-1 is a protein involved in a number of cellular
processes involving mainly DNA repair and programmed
cell death. PARP-1 is also known for its role in transcription
through remodelling of chromatin by PARylating histones
and relaxing chromatin structure, thus allowing transcription
complex to access genes. As shown in Fig. 2-I, ATX
treatment of ischemia rats at this dose (20 mg/kg) inhibited
PARP-1 cleavage compared with ischemia rats group.
Inhibition of NO and iNOS by ATX
To further understand the neuroprotective mechanisms of
ATX, we next investigated whether ATX protects SH-SY5Y
neuronal cells from oxidative injury. In the cells treated
with ATX (at a concentration of 10, 25 and 50 μM) for
30 min before being exposed OGD, the viability was
measured to be 73.81%, 92.95% and 110.76%, respectively
(Fig. 3-A, *p<0.05, **p<0.01, ***p<0.001). Next, the cells
were treated with OGD alone or with various concentrations
of ATX for 24 h. NO production was assayed by measuring
the levels of a stable NO metabolite, nitrites in the condi-
tioned medium. At the concentrations (10–50 μM) used in
this study, none of the OGD or ATX treatments caused
toxicity to cells as judged by the MTT assays (Fig. 3-A).
For determining the concentration-dependent relationship,
increasing concentrations of drug are used in a semi-log
scale. We are found that ATX acts from 5 to 100 μM both the
highest ineffective and the lowest effective concentrations,
respectively (Fig. 3-B). ATX treatment of SH-SY5Y cells
after OGD stress time-dependently decreased nitrite accu-
mulation. ATX at 50 μM concentration effectively inhibited
NO production by 70% by 24 h of culturing time in OGD-
stimulated SH-SY5Y cells (Fig. 3-C). To determine whether
the inhibitory ability of ATX on NO production was due to a
decrease in the cytosolic iNOS protein level, SH-SY5Y cells
were treated with OGD and ATX for 24 h, and the levels of
iNOS protein were detected by Western blotting. As shown
in Fig. 3-D, treatment with ATX led to a significant decrease
in iNOS protein levels. ATX (25 and 50 μM) inhibited
OGD-induced iNOS protein production by 20–60%.
ATX increases HSPs protein levels in the absence of oxida-
tive stress
We found that in the absence of OGD, ATX robustly
stimulated HO-1 (Hsp32) levels in a dose-dependent manner
(Fig. 4-A). HO-1 (Hsp32) is an anti-inflammatory enzyme,
shown to be important in the resolution of acute inflam-
matory responses. Also, HO-1 (Hsp32) is known to be
induced by a variety of stress-stimuli, such as heavy metals,
UV radiation and heat shock. To assess whether HO-1
(Hsp32) induction might contribute to the anti-oxidant
effects of ATX in SH-SY5Y cells, we tested to see if ATX
could induce HO-1 (Hsp32) production in SH-SY5Y cells.
The increases in HO-1 (Hsp32) levels reached a maximum
at 25 μM of ATX concentration. However, OGD alone did
not stimulate HO-1 (Hsp32) induction in SH-SY5Y cells nor
did it affect the ability of ATX to stimulate HO-1 (Hsp32)
(Data not shown). We also examined the ability of other
HSP to induce HO-1 (Hsp32) production in SH-SY5Y cells.
In addition to stimulating HO-1 (Hsp32), ATX also induced
an increase in another protective enzyme, Hsp70. As shown
in Fig. 4-B, the levels of Hsp70 increased in SH-SY5Y cells
treated with ATX (10 μM). The induction of HO-1 (Hsp32)
and the hsp70 could possibly represent upregulation of
antioxidant defense mechanisms in a cellular response to
oxidative stress. These data suggest that the stimulation of
HO-1 (Hsp32) and Hsp70 by ATX is a consequence of
oxidative stress as is decreased production of NO by inhibi-
tion of iNOS. However, our data do not rule out the possi-
bility that other forms of oxidative stress not examined in
this study might be induced by ATX.D.-H. Lee et al.
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Discussion
Recognition of the involvement of oxidative stress in
neurodegenerative diseases has generated substantial interest
in investigating the ability of naturally occurring antioxidant
phytochemicals to ameliorate neuronal damage associated
with neuro-degeneration and aging [17]. Previous studies
from our laboratory have demonstrated the ability of
falcarindial and baicalein, a antioxidants isolated from plants,
to ameliorate neuronal damage resulting from cerebral
ischemia [18, 19]. In the present study, we demonstrated
that administration of ATX showed neuroprotective effects
in a 4-VO-induced global cerebral ischemia model in
rats. ATX also significantly inhibited OGD-stimulated NO
production and iNOS protein expression in SH-SY5Y cell
lines.
In the animal study, ATX (30 mg/kg body wt) was
injected into Wistar rats within 30 min after ischemia.
Treatment with ATX after cerebral ischemia significantly
reduced the CA1 neuronal cell death up to 78% as compared
Fig. 3. Effect of ATX against oxidative stress in OGD-induced SH-SY5Y cells. (A, B) Cells were subjected to OGD then various
concentrations of ATX (10, 25 and 50 μM) were added for 24 h. ATX was not toxic to SH-SY5Y cells without OGD as
compared with SH-SY5Y cells with OGD. (C) Cells were OGD-induced then various concentrations of ATX (10, 25 and
50 μM) were added for 24 h. Nitrite content was measured using the Griess reaction. Values indicate nitrite production from
cells exposed to culture supernatants of OGD treated alone and cells exposed to OGD plus ATX. (D) Cell lysates were prepared
and subjected to Western blotting from control or cell OGD-induced, alone or in combination with increasing concentrations
(25 and 50 μM) of ATX for 24 h. Depicted is a Western blot of iNOS protein expression (upper panel) and the statistical
analysis of the changes of iNOS protein (lower panel). The β-actin level was considered as an internal control. Values represent
the mean ± SEM of five separate experiments on SH-SY5Y cells. Means data points were analyzed by one-way ANOVA,
followed by Dunnett’s posttest to compare all data with OGD-group. (*p<0.05, **p<0.01, ***p<0.001).Neuroprotective Effects of Astaxanthin in SH-SY5Y Cells
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to the control group. Death of CA1 hippocampal neurons
following cerebral ischemia caused a variety of neurological
dysfunctions. Although the exact mechanism of neuro-
logical damage caused by cerebral ischemia has yet to be
elucidated, the involvement of excitotoxicity, activation of
voltage-gated calcium channels, inflammatory cytokines,
and oxidative stress was reported [20]. One of the possible
ways to prevent free radical mediated cellular injuries is to
augment the oxidative defense capacity through intake of
antioxidants. ATX has a quenching capability against damage
from NO in vitro 80 times stronger than α-tocopherol and
twice as strong as β-carotene [21]. Hence, we cannot
exclude the possibility that the neuroprotection of ATX
against ischemia-induced neuronal damage may partially
depend on its anti-inflammatory and anti-oxidation activity.
Although our study used lower doses than those reported
by Hussein et al. [14], comparable protective effects were
obtained. Since most of these studies examined cell death at
one time point after ischemia/reperfusion, it is not possible
to conclude whether the protective effects of ATX are not
simply delaying the cell death process. Recently, a report
indicated that ATX significantly protected mitochondria be a
ROS scavenging in hyperglycemia-induced oxidative
damage [22]. In addition, ATX has been beneficial effects
for cognitive and psychomotor function in preliminary
clinical [23]. Consequently, more studies are needed to
examine the effects of ATX at prolonged times after ischemia.
NO production is enhanced at all stages of cerebral
ischemia and this increase is accompanied by up regulation
of both NOS activity and NOS gene expression [24]. While
NO has been reported to be toxic to cells through several
different mechanisms [25], we here demonstrate that NO
triggered by iNOS induction may contribute to an enhance-
ment of OGD-induced neuronal death. The iNOS can be
induced in neuronal cells after OGD insult in vitro. Further-
more, this inducement occurs in a short period of time (2–3 h
after ischemia), suggesting that NO can play an important
pathogenic role in cell damage that occurs in early stages of
cerebral ischemia [26].
Our studies showed that ATX in a dose dependent manner
can decrease the delivery of NO and the activity of iNOS in
OGD-induced SH-SY5Y cells. Moreover, we have found
that ATX can protect rat cerebral cortical and hippocampus
slices from injury induced by H2O2 (data not shown), which
is consistent with the protective effect of ATX, which
may be related to its antioxidant properties. Despite the
incomplete understanding of molecular mechanisms involved
with the proposed neuroprotective action of ATX, we
suggest that its inhibition of the NO/iNOS system plays a
significant role in reducing OGD-induced neuron cells
damage. The detailed mechanism by which ATX inhibits the
NO/iNOS system remains a subject for further investigation.
We investigated the effect of ATX on OGD-induced NO
production and iNOS protein expression in the SH-SY5Y
cells. Treatment of ATX inhibited iNOS protein expression
and NO accumulation after OGD stimulation. This implies
that ATX, which inhibits NO production through inhibiting
iNOS enzyme activity, has beneficial therapeutic effects in
the treatment of inflammation associated neurodegenerative
disease. Moreover the compound, even at the concentration
Fig. 4. Modulation of OGD-induced Hsp70 and HO-1 (Hsp32) expression by ATX. Cell lysates were prepared and subjected to
Western blotting from control or cell OGD-induced, alone or in combination with increasing concentrations (10, 25, 50 and
100 μM) of ATX for 24 h. Depicted is data of (A) Hsp70 or (B) Hsp32 protein expression (upper panel) and the statistical
analysis of the changes of (A) Hsp70 or (B) Hsp32 protein (lower panel). The β-actin level was considered as an internal
control. Data represent the mean ± SEM of three independent experiments.D.-H. Lee et al.
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of 50 μM, did not change cell viability. The data are in
agreement with previous reports showing that 10 to 50 μM
ATX do not cause cytotoxicity in RAW246.7 cell lines [10].
This implies that the inhibition of OGD-induced NO produc-
tion by ATX is not the result of its cytotoxicity on SH-SY5Y
cells.
HSPs are found in all organisms, and are induced in all
organs of all animals, including the brain, by heat, heavy
metals, ischemia and other types of stress [27]. Transient
whole-body hyperthermia or mild cerebral ischemia protect
against subsequent cerebral ischemic injury [28, 29]. In the
nervous system, HSPs are induced in a variety of patho-
logical conditions, including cerebral ischemia, neuro-
degenerative disorders, epilepsy, and trauma. A number of
in vitro studies show that both heat shock and HSP over-
production protect CNS cells against both necrosis and
apoptosis. Although prolonged exposure to conditions of
extreme stress is harmful and can lead to cell death, induc-
tion of HSP synthesis can result in stress tolerance and cyto-
protection against stress-induced molecular damage. There
is now strong evidence that overproduction of HSPs leads
to protection in several different models of nervous system
injury. Previous studies have shown that Hsp70 over-
expression protects cells from death induced by various
insults that cause either necrosis or apoptosis, including
hypoxia and ischemia/reperfusion, by inhibiting multiple
cell death pathways [30]. Two found that treatment of the
cells with low concentrations of ATX resulted in high
resistance to OGD-induced cell death, and ATX induced
HO-1 (Hsp32) and Hsp70 expression at low concentration in
SH-SY5Y cell lines. In the previous study, however, the
presence of NOS inhibitors suppressed both nitrite accumu-
lation and HO-1 mRNA expression. Modulation of HO-1
mRNA expression by iNOS-derived NO following stimula-
tion with OGD has also been reported in different brain
regions, particularly in the hippocampus and substantia
nigra in the in vivo rat model [31]. In previously reported,
in the in hemorrhage/resuscitation-induced injury reduced
cellular caspase-3 activity, and to preserve cellular ATP
levels thorough HSP-70 overexpression and then sub-
sequently to inhibit iNOS expression [32]. In addition,
overexpression of HSP 70 mRNA and of HSP 70 and HO-1
proteins and inhibition of iNOS mRNA induction in
endotoxin-induced hypertension rats with arsenite treatment
[33]. The effects of ATX relation to NOS activity and HSPs
induction need to be further investigated.
In conclusion, our results demonstrate that ATX protects
SH-SY5Y cells in an in vitro model of ischemia/reperfusion
through inhibition of NO production and HSPs modulation.
Also, the administration of ATX during the early stage of
cerebral ischemia/reperfusion protects against neuronal
cell death in the hippocampal CA1 area of animal model.
Additional  in vitro and in vivo studies are necessary to
determine whether ATX can be used as a preventive agent
against acute neurodegenerative conditions, or to reduce the
progression of chronic and age-associated neurodegenera-
tive disorders, such as Alzheimer’s disease and Parkinson’s
disease.
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